US Venture Partners X LP

10% OwnereFFECTOR Therapeutics, Inc. (EFTR) · full profile →Form 4 · filed Jul 19, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$76K
Net Open-Market Flow
-$76K
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 19, 2022Sell(S)84$1.00$84134K
Jul 19, 2022Sell(S)3K$1.00$3K4.2M
Jul 18, 2022Sell(S)20K$1.08$22K4.2M
Jul 18, 2022Sell(S)635$1.08$686134K
Jul 15, 2022Sell(S)44K$1.11$49K4.2M
Jul 15, 2022Sell(S)1K$1.11$2K135K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-22-016514) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about EFTR insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001062993-22-016514"
Ask your agent
Use Arkolith to summarize insider buying and selling at eFFECTOR Therapeutics, Inc.
over the last 90 days and cite the filings.